Orthostatic plasma norepinephrine level as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndrome
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Postural tachycardia syndrome (POTS) is a heterogeneous disorder that creates challenges for treatment. Beta-blocker was one of the most commonly used drugs, but it is inconsistently effective. The purpose of this study is to explore whether orthostatic plasma norepinephrine level could be an indicator of therapeutic effectiveness of metoprolol for POTS in children. METHODS: Twenty-seven children with POTS were enrolled in our study. They received metoprolol treatment, and their orthostatic plasma norepinephrine levels were measured by high-performance liquid chromatography method. Three months after rmetoprolol treatment, 25 patients were followed up. A receiver-operating characteristic (ROC) curve was used to explore the predictive value of orthostatic plasma norepinephrine level. RESULTS: The symptom severity and increment of heat rate from supine position to upright of patients positively correlated with their orthostatic plasma norepinephrine level (r=0.599, P<0.001; r=0.633, P<0.001, respectively). Orthostatic plasma norepinephrine level in responders to metoprolol was significantly higher than that of nonresponders (P=0.028). A ROC curve on the predictive value of orthostatic plasma norepinephrine level showed that the area under the curve was 0.785. Using a cutoff value for orthostatic plasma norepinephrine level of 3.59 pg/ml yielded both sensitivity (76.9%) and specificity (91.7%) in predicting the efficacy of metoprolol therapy for POTS. CONCLUSION: Orthostatic plasma norepinephrine level of>3.59 pg/ml was an indicator of the effectiveness of metoprolol therapy for POTS in children and adolescents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Freeman, R., Wieling, W., Axelrod, F. B., Benditt, D. G., Benarroch, E., Biaggioni, I., Cheshire, W. P., Chelimsky, T., Cortelli, P., Gibbons, C. H., et al. (2011) · Clinical Autonomic Research · doi:10.1007/s10286-011-0119-5 · Cited by 1,697
Freeman, R., Wieling, W., Axelrod, F. B., Benditt, D. G., Benarroch, E., Biaggioni, I., Cheshire, W. P., Chelimsky, T., Cortelli, P., Gibbons, C. H., et al. (2011) · Autonomic Neuroscience · doi:10.1016/j.autneu.2011.02.004 · Cited by 1,243
Postural orthostatic tachycardia syndrome: the Mayo clinic experience
Thieben, M. J., Sandroni, P., Sletten, D. M., Benrud-Larson, L. M., Fealey, R. D., Vernino, S., Low, P. A., Lennon, V. A., & Shen, W.-K. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61027-6 · Cited by 516
Postural tachycardia syndrome: a heterogeneous and multifactorial disorder
Benarroch, E. E. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.08.013 · Cited by 370 · cited 3×
“Although the underlying causes of POTS remain unclear, several mechanisms have been proposed, including sympathetic activation, hypovolemia, and partial autonomic neuropathy [1-4].”
Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.
Goldstein, D. S., Eisenhofer, G., Stull, R., Folio, C. J., Keiser, H. R., & Kopin, I. J. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113298 · Cited by 245 · cited 1×
“Plasma catecholamine levels were determined by high-performance liquid chromatography with electrochemical detection [19].”
Raj, S. R., Black, B. K., Biaggioni, I., Paranjape, S. Y., Ramirez, M., Dupont, W. D., & Robertson, D. (2009) · Circulation · doi:10.1161/circulationaha.108.846501 · Cited by 225 · cited 2×
“reported that low-dose oral propranolol significantly attenuated tachycardia and improved symptoms in POTS, and higher-dose propranolol did not further improve, and might worsen symptoms [8].”
Quality of Life in Patients With Postural Tachycardia Syndrome
Benrud-Larson, L. M., Dewar, M. S., Sandroni, P., Rummans, T. A., Haythornthwaite, J. A., & Low, P. A. (2002) · Mayo Clinic Proceedings · doi:10.4065/77.6.531 · Cited by 217
Postural tachycardia in children and adolescents: what is abnormal?
Singer, W., Sletten, D. M., Opfer-Gehrking, T. L., Brands, C. K., Fischer, P. R., & Low, P. A. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.08.054 · Cited by 209
Fu, Q., VanGundy, T. B., Shibata, S., Auchus, R. J., Williams, G. H., & Levine, B. D. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.172262 · Cited by 175
Sleep Disturbances and Diminished Quality of Life in Postural Tachycardia Syndrome
Bagai, K., Song, Y., Ling, J. F., Malow, B., Black, B. K., Biaggioni, I., Robertson, D., & Raj, S. R. (2011) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.28110 · Cited by 134
Research works printed but not linked: 9
- Medow MS: Postural tachycardia syndrome from a pediatrics perspective. J Pediatr. 2011, 158: 4-6. 10.1016/j.jpeds.2010.08.038. · DOI
- Jarjour IT: Postural tachycardia syndrome in children and adolescents. Semin Pediatr Neurol. 2013, 20: 18-26. 10.1016/j.spen.2013.01.001. · DOI
- Zhang Q, Du J, Wang Y: The efficacy of β-blocker plus oral saline in the treatment of children with postural orthostatic tachycardia syndrome. J Clin Pediatr (Chinese). 2006, 24: 357-362.
- Ladage D, Schwinger RH, Brixius K: Cardio-selective beta-blocker: pharmacological evidence and their influence on exercise capacity. Cardiovasc Ther. 2013, 31: 76-83. 10.1111/j.1755-5922.2011.00306.x. · DOI · Paper page
- Zhang F, Li X, Ochs T, Chen L, Liao Y, Tang C, Jin H, Du J: Midregional pro-adrenomedullin as a predictor for therapeutic response to midodrine hydrochloride in children with postural orthostatic tachycardia syndrome. J Am Coll Cardiol. 2012, 60: 315-320. 10.1016/j.jacc.2012.04.025. · DOI · Paper page
- Winker R, Barth A, Dorner W, Mayr O, Pilger A, Ivancsits S, Ponocny I, Heider A, Wolf C, Rüdiger HW: Diagnostic management of orthostatic intolerance in the workplace. Int Arch Occup Environ Health. 2003, 76: 143-150. · DOI
- Winker R, Barth A, Bidmon D, Ponocny I, Weber M, Mayr O, Robertson D, Diedrich A, Maier R, Pilger A, Haber P, Rüdiger HW: Endurance exercise training in orthostatic intolerance: a randomized, controlled trial. Hypertension. 2005, 45: 391-398. 10.1161/01.HYP.0000156540.25707.af. · DOI · Paper page
- Convertino VA, Sather TM: Effects of cholinergic and beta-adrenergic blockade on orthostatic tolerance in healthy subjects. Clin Auton Res. 2000, 10: 327-336. 10.1007/BF02322256. · DOI · Paper page
- Masuki S, Eisenach JH, Schrage WG, Johnson CP, Dietz NM, Wilkins BW, Sandroni P, Low PA, Joyner MJ: Reduced stroke volume during exercise in postural tachycardia syndrome. J Appl Physiol. 2007, 103: 1128-1135. 10.1152/japplphysiol.00175.2007. · DOI · Paper page
Cited by
Vernino, S., Bourne, K. M., Stiles, L. E., Grubb, B. P., Fedorowski, A., Stewart, J. M., Arnold, A. C., Pace, L. A., Axelsson, J., Boris, J. R., et al. (2021) · Autonomic Neuroscience · doi:10.1016/j.autneu.2021.102828 · Cited by 304
Efficacy of Therapies for Postural Tachycardia Syndrome: A Systematic Review and Meta-analysis
Wells, R., Elliott, A. D., Mahajan, R., Page, A., Iodice, V., Sanders, P., & Lau, D. H. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.01.025 · Cited by 67
Dizziness and orthostatic intolerance in pediatric headache patients
Qubty, W., & Kedia, S. (2016) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2016.01.004 · Cited by 12
Bai, W., Han, Z., Chen, S., Li, H., Song, J., Qi, J., Liao, Y., Tang, C., Liu, P., Wang, Y., et al. (2017) · Pediatric Cardiology · doi:10.1007/s00246-017-1708-4 · Cited by 8
Self-citation
Metadata
- Authors
- Zhang, Q., Chen, X., Li, J., & Du, J.
- Venue
- Journal of Translational Medicine
- Published
- 2014-09-10
- Volume
- 12
- Issue
- 1
- Pages
- 249-249
- ISSN
- 1479-5876 (ISSN-L)
- OpenAlex
- W2124150162
- Cited by
- 44
- References
- 21
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Orthostatic plasma norepinephrine level as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndrome. https://app.cochat.ai/papers/10.1186/s12967-014-0249-3
- The paper
- Zhang, Q., Chen, X., Li, J., & Du, J. (2014). Orthostatic plasma norepinephrine level as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndrome. Journal of Translational Medicine. https://doi.org/10.1186/s12967-014-0249-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.